The clinical application of DNA content and kinetic parameters in the treatment of patients with squamous cell carcinomas of the head and neck

Cancer and Metastasis Reviews

Volumn 15, Issue 1, 1996, Pages 133-141

  Ensley, John F ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

DNA content parameters; DNA ploidy; flow cytometry; percent S phase fraction; squamous cell carcinomas of the head and neck (SCCHN); treatment outcome; tumor response

Indexed keywords

ANTINEOPLASTIC AGENT;

DNA CONTENT; HEAD AND NECK CARCINOMA; HUMAN; KINETICS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE; DNA, NEOPLASM; HEAD AND NECK NEOPLASMS; HUMANS; PLOIDIES; TREATMENT OUTCOME;

EID: 0029935837     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00049492     Document Type: Review

References (40)

1. Broders AC: Carcinoma grading and practical application. Arch Path 2: 376-381, 1926
2. Sandberg AA: The cytogenetics of solid tumors. Adv Oncol 8: 2-9, 1992
3. Sandberg AA: The Chromosomes of Human Cancer and Leukemia. Elsevier Science Publishing Inc., N.Y., N.Y., 1984, pp 426-457
4. Ensley JF: Molecular Medicine: The Forest, Trees and Leaves. Arch Otolaryngol Head and Neck Surg 119: 1173-1177, 1993
5. Jacobsson PA, Eneroth CM, Killander D, Mobeiger G, Mortensson B: Histologic classification and grading of malignancy of the larynx. Acta Radiologica 12: 1-18, 1972
6. Atkin NB, Richards BM: Deoxyribonucleic acid in human tumors measured by microspectrophotometry of Feulgen strain: A comparison of tumors arising from different sites. Br J Cancer 10: 769-786, 1957
7. Ensley JF, Maciorowski Z, Hassan M, Pietraszkiewicz, Kish J. Tapazoglou E, Jacobs J, Mathog R, Weaver A, Atkinson D, Binns P, Ahmed K, Al-Sarraf M, Sakr W, Zarbo R, Crissman J: The potential and pitfalls of solid tumor flow cytometry with respect to squamous cell cancers of the head and neck. In: Wolf GT, Carey T (eds) Proceeding of the Second International Research Conference on Head and Neck Cancer, Kugler Publishers, Amsterdam, Holland, 1988, pp 213-224
8. Hitchcock CL, Ensley JF: Technical considerations for the analysis of fresh and archival solid human tumors. In: Bauer DK, Dique RE, Shankey TV (eds) Clinical Flow Cytometry Principles and Application, 1992, pp 93-110
9. Barlogie B, Raber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, Gohde W, Andreeff M, Freireich E: Flow Cytometry in Clinical Cancer Research. Cancer Res 43: 3977-3982, 1983
10. Kamentsky LA, Melamed MR: Spectrophotometric cell sorter. Science 156: 1364-1370, 1967
11. Crissman J, Ensley J: Histopathology as a prognostic factor in the treatment of squamous cell cancer of the head and neck. In: Jones M, Strong E (eds) Current Therapy of Head and Neck Cancer, B.C. Decker, Inc., Philadelphia, PA, 1986, pp 92-96
12. Ensley J, Maciorowski M: Clinical application of DNA content parameters in patients with squamous cell carcinomas of the head and neck. Seminars in Oncology 21: 330-339, 1994
13. Ensley J, Crissman J, Kish J, Jacobs J, Weaver A, Kinzic J, Cummings G, Al-Sarraf M: The impact of morphological analysis on response rates and survival in patients with squamous cell cancer of the head and neck. Cancer 57: 711-717, 1986
14. Ensley JF, Maciorowski Z, Kish JA, Al-Sarraf M: The significance of pretreatment identification of prognostically important subgroups of squamous cell cancer of the head and neck. In: Jacobs J, Al-Sarraf M, Crissman J, Valeriote F (eds) Scientific and Clinical Perspective of Head and Neck Cancer Management Strategics for Cure. Elsevier Inc., N.Y., N.Y., 1987, pp 35-56
15. Ensley JF, Kish JA, Al-Sarraf M: The pretherapeutic identification of prognostically important parameters predictive of tumor response in squamous cell cancers of the head and neck. In: Vogl S (ed.) Head and Neck Cancer, Churchill Livingstone. Inc., New York, 1988, pp 109-124
16. Ensley J, Crissman J, Kish J, Weaver A, Jacobs J, Cummings G, Al-Sarraf M: The correlation of individual parameters of tumor differentiation with response rate and survival in patients with advanced head and neck cancer treated with induction therapy. Cancer 63: 1487-1492, 1989
17. Sakr W, Hassan M, Zarbo R, Ensley J, Crissman JD: DNA quantitation and histologic characteristics ot squamous cell carcinomas of the upper acrodigestive tract. Arch Pathol and Lab Medicine 113: 1009-1014, 1989
18. Ensley JF, Maciorowski Z, Pietraszkiewicz H, deBraud F, Sakr W: Methodology and clinical applications of cellular DNA content parameters determined by flow cytometry in squamous cell cancers of the head and neck. Cancer Treat Res 52: 225-242, 1990
19. Ensley JF, Maciorowski Z, Hassan M, Pietraszkiewicz H, Heilbrun L, Kish JA, Tapazoglou E, Jacobs JR, Al-Sarraf M: Cellular DNA content parameters in untreated and recurrent squamous cell cancers of the head and neck. Cytometry 10: 334-338, 1989
20. Ensley JF, Maciorowski Z, Pietraszkiewicz H, Klemic G, KuKuruga M, Sapareto S, Corbett T, Crissman JD: Solid tumor preparation for flow cytometry using a standard murine tumor model. Cytometry 8: 479-487, 1987
21. Ensley JF, Maciorowski Z, Pietraszkiewicz H, Hassan M, Kish J, Al-Sarraf M, Jacobs J, Weaver A, Atkinson D, Crissman J: Tumor preparation for clinical application of flow cytometry. Cytometry 8: 488-493, 1987
22. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324: 1685-1690, 1991
23. Adjuvant chemotherapy for advanced head and neck squamous carcinoma: Final report of the Head and Neck Contracts Program. Cancer 59: 301-311, 1987
24. Ervin TJ, Clark JR, Weichselbaum RR, Fallon BG, Miller D, Fabian R, Posner M, Norris CM, Tuttle SA, Schoenfeld DA, Proce KN, Frei III E: An analysis of induction and adjuvant chemotherapy in multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 5: 10-20, 1987
25. Laramore GE, Scott CB, Al-Sarraf M, Haselow RE, Wheeler R, Jacobs JR, Schuller D, Gahbauer RA et al.: Adjuvant chemotherapy in resectable squamous carcinomas of the head and neck. Report of Intergroup 0034. Int J Radiat Oncol Biol Phys 23: 705-713, 1992
26. Tennevall J, Wennergerg J, Andereon H, Baldetorp B, Ferno M, Willen R: DNA analysis as a predictor of outcome of induction chemotherapy in advanced head and neck carcinomas. Arch Otololaryngol Head and Neck Surg 119: 867-870, 1993
27. Cooke LD, Cooke TG, Bootz F, Forster G, Helliwell TR, Spiller D, Stell PM: Pliody as a prognostic indicator in end stage squamous cell carcinomas of the head and neck region treated with cisplatinum. Br J Cancer 61: 759-762, 1991
28. Gregg CM, Beals TE, McClatchy KM, Fisher SG, Wolf GT: DNA content and tumor response to induction chemotherapy in patients with advanced laryngeal squamous cell carcinomas. Otololaryngol Head and Neck Surg 108: 731-737, 1993
29. Ensley J, Pietraskiewicz H, Maciorowski Z, Hassan M, Kish J, Tapazoglou E, Jacobs J, Weaver A, Atkinson D, Binns P, Al-Sarraf M: Comparative techniques and clinical correlation of cell cultures from squamous cell carcinomas of the head and neck. In: Wolf GT, Carey T (eds) Proceeding of the Second International Head and Neck Research Conference. Kugler Publishers, Amsterdam, Holland, 1988, pp 35-41
30. Ensley J, Maciorowski Z, Pietraszkiewicz H, Reed M: DNA ploidy transformations in new head and neck cancer cell lines (SCCHN): Implications for cytotoxic response. Cancer Res 31: 23, 1990 (abstr)
31. Ensley J, Pietraszkiewicz H, Pear A, Sakr W, Alonso M, Maciorowski Z: The selection of patients with squamous cell carcinoma of the head and neck for clinical trials based on tumor DNA content parameters. In: Salmon SE (ed.) Adjuvant Therapy of Cancer, Vol VII, Grune & Stratum, Orlando, FLA, pp 99-110, 1993
32. Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 70: 523-526, 1992
33. Tamura G, Kihana T, Noruma K, Terasam M, Sugimura T, Hiroshashi S: Detection of frequent p53 mutations in primary gastric cancer by cell sorting and polymerase chain reaction, single strand conformation polymorphism analysis. Cancer Res 51: 3056-3058, 1991
34. Maesawa C, Tamura C, Suzuki Y: Aberrations of tumor suppressor genes (p53, APC, MMC and Pb) in esophageal squamous cell carcinoma with references to prognosis. Cancer Res 24: 225, 1993 (abstr)
35. Ensley J, Alonso M, Naik H, Pear A, Pietraszkiewicz H, Sarkar A, Wozniak A, Kraut M, Valdivieso M: Comparative DNA content analysis of non-small cell cancers of the lung (NSCCL), their correlation with other inter-mediate markers and clinical outcome. Cancer Res 35: 1411, 1994 (abstr)
36. Ensley J, Maciorowski Z, Pietraszkiewicz H, Lane MA, Alonso M: Development and validation of a flow cytometric assay for the single cell determination of p53 expression in squamous cell cancers of the head and neck. Cancer Res 34: 540, 1993 (abstr)
37. Ensley J, Pietraszkiewicz H, Maciorowski Z, Alonso M, Pear A, Wolman S, Robbins K, Lane MA: Alterations in DNA content, cytogenetics and molecular genetics accompanying an aneuploid transformation in a long standing pseudo diploid squamous cell cancer of the head and neck cell line. Cancer Res 34: 210, 1993 (abstr)
38. Yendall WA, Crawford RY, Ensley JF, Robbins KC: MTSI/CDk41 is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis 15: 2683-56, 1994
39. Cardinalli M, Pietraszkiewicz H, Ensley JF, Robbins KC: Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies. Int J Cancer 61: 98-103, 1995
40. Lo KW, Mok CH, Chung G, Huang DP, Wong F, Chan M, Lee JC, Tsao SW: Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection. Anticancer Res 12: 1989-1994, 1992